Skip to main content

Books
Documents
Publishers
Topics
Lists
Modules

Register Login

Home
Organizations
CADTH
CoherenceBot
CADTH Reimbursement Review - Guselkumab …
Table

Coherent Identifier

20.500.12592/5cf8mg

Table 1 on page 11

Found in: CADTH Reimbursement Review - Guselkumab (Tremfya) - Sponsor: Janssen Inc. …

For copyright status please check original publication.

Citation

Health, C., 2023. CADTH Reimbursement Review - Guselkumab (Tremfya) - Sponsor: Janssen Inc. Therapeutic Area: Psoriatic arthritis, Canadian Agency for Drugs and Technologies in Health. Canada Retrieved from https://canadacommons.ca/artifacts/3780265/cadth-reimbursement-review-guselkumab-tremfya-sponsor/4586027/fragments/2304814/ on 19 May 2024. CID: 20.500.12592/26kmtv.

Download citation (RIS)

Share

Social:

Twitter Facebook Linkedin Email

URL:

Accessing this content requires a membership

Check your affiliation Start a trial

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Change

Add to list

Manage your lists

Create your FREE account to get started

About

Canada Commons
Our Vision
The Team
Accessibility & VPAT

Membership

Request a Demo
Sales Inquiries
Help

Newsletter

Email address

Copyright © Coherent Digital, LLC

Terms of Use · Privacy Policy · File Upload Policy

Please register or log in to continue using the site

Register Login

If your institution is a member, please log into Policy Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.